Found 551 matching trials
Exercise Testing in Diseases and Health
NACardiopulmonary exercise test (CPET) is a helpful tool for evaluation of ae...
Location
The BARUCH PADEH Medical Center, Poriya
CART-meso in Mesothelin Expressing Cancers
PHASE1Phase I study to establish safety and feasibility of intravenously administ...
Location
Abramson Cancer Center of the University of Pennsylvania
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients
N/AThe role of miRNAs in HIV disease is yet to be completely defined. Host miR...
Location
Institut Pasteur du Cambodge
Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).
PHASE1This Phase I/IIa clinical study is testing an experimental treatment called...
Location
Hospital Clínic de Barcelona
PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer
PHASE1PD1-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer...
Location
The First Affiliated Hospital, Zhejiang University
Safety and Efficacy Evaluation of IM23 CAR-T Cells (IM23CAR-T)
PHASE1Assessment of the Safety and Feasibility of Administering T Cells Expressin...
Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors
PHASE1RATINALE: Placing a tumor antigen chimeric receptor that has been created i...
Location
Chinese PLA General Hospital
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma
PHASE1This phase I trial studies the side effects and best dose of BCMA CART cell...
Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_PHASE1This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology